Having worked in the British, French and Swiss financial press, Romain is able to report on local and international issues, as comfortable in French as in the language of Shakespeare, Romain Fournier leads the editorial team at Marketscreener. Fine connoisseur of the English-speaking markets, Romain delivers an editorial every day on US and UK markets.
Analyst recommandations: AstraZeneca, General Electric, Parker-Hannifin, PayPal, Qiagen...
Every day, find a selection of analysts' recommendations covering North America and the UK. The list only includes companies that have been the subject of a change of opinion or price target, or a new coverage. It may be updated during the session. This information is used to shed light on the movements of certain stocks or the market sentiment on a company.
AstraZeneca: Barclays still consider the stock as a Buy opportunity. The target price has been revised upwards and is now set at GBp 11000, compared with GBp 10000 previously.
AudioBoom Group: Finncap initiated coverage with a recommendation of corporate. PT rises 47% to 1,600 pence.
Babcock: Barclays cut the recommendation to equal-weight from overweight. PT up 9% to 352 pence=
ConocoPhillips: Societe Generale cut the recommendation on ConocoPhillips to hold from buy. PT up 1.7% to $77
Five9: JPMorgan adjusts price target to $160 from $213, maintains neutral rating
General Electric: Deutsche Bank raised the recommendation to buy from hold. PT up 18% to $131
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
